Sampo plc
Sampo plc’s share buybacks 8 December 2025
Sampo plc’s share buybacks 8 December 2025
Sampo plc, stock exchange release, 9 December 2025 at 8:30 am EET
Sampo plc’s share buybacks 8 December 2025
On 8 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:
| Sampo plc’s share buybacks | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares* | Market (MIC Code) |
| 5,416 | 9.96 | AQEU | |
| 105,692 | 9.96 | CEUX | |
| 23,845 | 9.96 | TQEX | |
| 126,805 | 9.96 | XHEL | |
| TOTAL | 261,758 | 9.96 |
* rounded to two decimals
On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November 2025, is based on the authorisation granted by Sampo's Annual General Meeting on 23 April 2025.
After the disclosed transactions, the company owns in total 5,610,380 Sampo A shares representing 0.21 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Morgan Stanley
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Politecnico Milano10.12.2025 19:35:25 CET | Press release
Three new Bachelors of the Politecnico di Milano, delivered entirely in English, in three cities
CARRICK THERAPEUTICS LIMITED10.12.2025 19:30:00 CET | Press release
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
Atlantica Sustainable Infrastructure LTD10.12.2025 19:18:17 CET | Press release
Atlantica Closes the Acquisition of Statkraft's Renewable Energy Platform in Canada
Theon International PLC10.12.2025 18:37:20 CET | Press release
THEON signs the largest contract ever for 100,000 NVGs with OCCAR, valued at c.€1 billion
Tralent Online Gaming Services Co. L.L.C.10.12.2025 18:30:07 CET | Press release
Tralent Launches Skill-Based Trading Tournament Platform with Fixed Risk and High-Reward Potential
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom